$AGTX
Agentix Corp.

2023 Q2 Form 10-K Financial Statement

#000147793223005252 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $240.0K $245.3K $660.3K
YoY Change 111.38% -87.31% -69.29%
% of Gross Profit
Research & Development $158.2K $183.8K $711.5K
YoY Change 209.48% 118.72% 404.62%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $401.1K $429.1K $1.372M
YoY Change 143.62% -78.73% -40.13%
Operating Profit -$401.1K -$429.1K -$1.372M
YoY Change 143.62% -78.73% -40.13%
Interest Expense -$10.00K -$2.050K -$2.050K
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.423K $2.049K
YoY Change
Pretax Income -$409.6K -$431.2K -$1.374M
YoY Change 148.74% -78.63% -40.04%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$403.3K -$431.2K -$1.374M
YoY Change 144.94% -78.63% -40.04%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$0.04
COMMON SHARES
Basic Shares Outstanding 40.07M shares 40.07M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.860K $12.37K $12.37K
YoY Change 2984.21% 406.97% 8146.67%
Cash & Equivalents $5.856K $12.37K
Short-Term Investments
Other Short-Term Assets $324.6K $249.0K $249.0K
YoY Change 2897.6% 1473.09% 1473.09%
Inventory
Prepaid Expenses $298.3K $199.3K
Receivables
Other Receivables
Total Short-Term Assets $330.5K $261.4K $261.4K
YoY Change 2898.55% 1535.94% 1535.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $330.5K $261.4K $261.4K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $330.5K $261.4K $261.4K
YoY Change 2898.55% 1535.94% 1535.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.327M $2.451M $2.451M
YoY Change 751.68% 1589.27% 124.31%
Accrued Expenses $13.99K $9.110K $9.110K
YoY Change 13892.0% 9010.0% 9010.0%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $50.00K $50.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.983M $2.511M $2.511M
YoY Change 138.13% 129.7% 129.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.983M $2.511M $2.511M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.983M $2.511M $2.511M
YoY Change 138.13% 129.7% 129.7%
SHAREHOLDERS EQUITY
Retained Earnings -$5.779M -$5.369M
YoY Change 38.91% 34.38%
Common Stock $40.07K $40.07K
YoY Change 2.96% 2.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.652M -$2.249M -$2.249M
YoY Change
Total Liabilities & Shareholders Equity $330.5K $261.4K $261.4K
YoY Change 2898.55% 1535.94% 1535.73%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$403.3K -$431.2K -$1.374M
YoY Change 144.94% -78.63% -40.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$62.76K -$41.30K -$88.54K
YoY Change -142738.64% -3541.67% 5365.43%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $50.00K 50.00K 100.0K
YoY Change
NET CHANGE
Cash From Operating Activities -$62.76K -41.30K -88.54K
Cash From Investing Activities $0.00 0.000 0.000
Cash From Financing Activities $50.00K 50.00K 100.0K
Net Change In Cash -$6.513K 8.700K 11.46K
YoY Change -14902.27% 625.0% -807.41%
FREE CASH FLOW
Cash From Operating Activities -$62.76K -$41.30K -$88.54K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1394230 usd
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
947757 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2626631 usd
CY2023 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39232019 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12369 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2627310 usd
CY2023Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
53535 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001603345
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38916951 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40066951 shares
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
0 shares
CY2022Q1 agtx Common Stock Shares Outstanding1
CommonStockSharesOutstanding1
38916951 shares
CY2023Q1 agtx Common Stock Shares Outstanding1
CommonStockSharesOutstanding1
40066951 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Entity File Number
EntityFileNumber
000-55383
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
AGENTIX CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2876282
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
32932 Pacific Coast Highway
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
#14-254
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Dana Point
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92629
CY2023 dei City Area Code
CityAreaCode
321
CY2023 dei Local Phone Number
LocalPhoneNumber
299-2014
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $.001 par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
4678014 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40066931 shares
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145 usd
CY2023Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
50000 usd
CY2022Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38916951 shares
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
765 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
1240 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561 usd
CY2023 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
679 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
520238 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
2182043 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
711506 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
279912 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
140012 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
165355 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1371756 usd
CY2023 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1643 usd
CY2022 us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
CY2023 us-gaap Other Expenses
OtherExpenses
2049 usd
CY2022 us-gaap Other Expenses
OtherExpenses
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1373805 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2626631 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1373805 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
765 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1373040 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2626631 usd
CY2023 agtx Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.04
CY2022 agtx Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.07
CY2022 agtx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
38916951 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-220366 usd
CY2022 agtx To Be Issued Amount
ToBeIssuedAmount
0 usd
CY2022 agtx Common Stock Issued To Management Amount
CommonStockIssuedToManagementAmount
1500000 usd
CY2022 agtx Common Stock Issued To Consultants Amount
CommonStockIssuedToConsultantsAmount
249999 usd
CY2022 agtx Common Stock Issued For Software Amount
CommonStockIssuedForSoftwareAmount
20000 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
50000 usd
CY2023 agtx Shares Issued To Board Member For Services Amount
SharesIssuedToBoardMemberForServicesAmount
30600 usd
CY2023 agtx Shares Issued To Consultants For Services Amount
SharesIssuedToConsultantsForServicesAmount
45900 usd
CY2023 agtx Shares Granted For Software
SharesGrantedForSoftware
32000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
765 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1373805 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2249163 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1373805 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2626631 usd
CY2023 agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
19954 usd
CY2022 agtx Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
0 usd
CY2023 agtx Stock Issued During Period Value Issued
StockIssuedDuringPeriodValueIssued
118875 usd
CY2022 agtx Stock Issued During Period Value Issued
StockIssuedDuringPeriodValueIssued
1769999 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-221143 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
34167 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1367579 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
797261 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88541 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25204 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
50000 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
765 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12224 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25204 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25349 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12369 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 agtx Issuance Of Stock For Software Subscription
IssuanceOfStockForSoftwareSubscription
32000 usd
CY2022 agtx Issuance Of Stock For Software Subscription
IssuanceOfStockForSoftwareSubscription
20000 usd
CY2023Q1 us-gaap Cash
Cash
12369 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period.  Among other things, management estimates include the assumptions made for accruals and potential liabilities and realization of deferred tax assets.  These estimates generally involve complex issues and require judgments, involve analysis of historical information and the prediction of future trends, and are subject to change from period to period. Actual amounts could differ significantly from these estimates.</p>
CY2023 agtx Accounting For Leases
AccountingForLeases
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset (“ROU”) and a lease liability for virtually all leases.  Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company uses an implicit rate of interest to determine the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable.  The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. As of March 31, 2023 and 2022, the Company did not have any leases.</p>
CY2023Q1 agtx Shares Issued For Software
SharesIssuedForSoftware
27879 usd
CY2022Q1 agtx Shares Issued For Software
SharesIssuedForSoftware
15833 usd
CY2023 agtx Provision For Inventory
ProvisionForInventory
49439 usd
CY2023 agtx Software Subscription
SoftwareSubscription
32000 usd
CY2022 agtx Software Subscription
SoftwareSubscription
20000 usd
CY2023Q1 us-gaap Share Price
SharePrice
0.10
CY2022Q1 us-gaap Share Price
SharePrice
0.89
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40066951 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38916951 shares
CY2023 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
307102 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
22346 shares
CY2023Q1 agtx Common Stock To Be Issued
CommonStockToBeIssued
307102 shares
CY2022Q1 agtx Common Stock To Be Issued To Related Party
CommonStockToBeIssuedToRelatedParty
3500000 shares
CY2022Q1 agtx Common Stock To Be Issued
CommonStockToBeIssued
520000 shares
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1132000 usd
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
827000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1132000 usd
CY2022Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
827000 usd
CY2023 agtx Federal Statutory Income Tax Rate Description
FederalStatutoryIncomeTaxRateDescription
The Company’s blended federal statutory income tax rate was 21% of which a NOL carry-forwards blended rate of 21% offset this rate and thus the effective income tax rate was %nil

Files In Submission

Name View Source Status
0001477932-23-005252-index-headers.html Edgar Link pending
0001477932-23-005252-index.html Edgar Link pending
0001477932-23-005252.txt Edgar Link pending
0001477932-23-005252-xbrl.zip Edgar Link pending
agtx-20230331.xsd Edgar Link pending
agtx_10k.htm Edgar Link pending
agtx_10kimg2.jpg Edgar Link pending
agtx_ex101.htm Edgar Link pending
agtx_ex211.htm Edgar Link pending
agtx_ex311.htm Edgar Link pending
agtx_ex312.htm Edgar Link pending
agtx_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
agtx-20230331_cal.xml Edgar Link unprocessable
agtx-20230331_def.xml Edgar Link unprocessable
agtx-20230331_lab.xml Edgar Link unprocessable
agtx-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agtx_10k_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending